Imaging in Alzheimer's disease
Neuroimaging in the early differential diagnosis of dementia has gained considerable interest over the last decade. From being used for exclusive purposes only, neuroimaging is now in the forefront of aiding in the diagnosis of Alzheimer's disease (AD), frontotemporal dementia, vascular dementi...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Les Laboratoires Servier
2009
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181915/ |
| id |
pubmed-3181915 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-31819152011-10-27 Imaging in Alzheimer's disease Scheltens, Philip Clinical Research Neuroimaging in the early differential diagnosis of dementia has gained considerable interest over the last decade. From being used for exclusive purposes only, neuroimaging is now in the forefront of aiding in the diagnosis of Alzheimer's disease (AD), frontotemporal dementia, vascular dementia, and and dementia with Lewy bodies (DLB). With the exception of dopamine transporter single photon-emission computed tomography imaging in DLB, imaging has not yet been incorporated into the diagnostic criteria for the various dementia syndromes, but that will soon change. The recently formulated research criteria for early AD recently formulated by Dubois et al explicitly mention magnetic resonance imaging and positron emission tomography for AD, and are an example of a new diagnostic process developing. In this review, the various imaging techniques will be highlighted, with an emphasis on their ability to diagnose Alzheimer's disease and separate it from other entities. Les Laboratoires Servier 2009-06 /pmc/articles/PMC3181915/ /pubmed/19585954 Text en Copyright: © 2009 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Scheltens, Philip |
| spellingShingle |
Scheltens, Philip Imaging in Alzheimer's disease |
| author_facet |
Scheltens, Philip |
| author_sort |
Scheltens, Philip |
| title |
Imaging in Alzheimer's disease
|
| title_short |
Imaging in Alzheimer's disease
|
| title_full |
Imaging in Alzheimer's disease
|
| title_fullStr |
Imaging in Alzheimer's disease
|
| title_full_unstemmed |
Imaging in Alzheimer's disease
|
| title_sort |
imaging in alzheimer's disease |
| description |
Neuroimaging in the early differential diagnosis of dementia has gained considerable interest over the last decade. From being used for exclusive purposes only, neuroimaging is now in the forefront of aiding in the diagnosis of Alzheimer's disease (AD), frontotemporal dementia, vascular dementia, and and dementia with Lewy bodies (DLB). With the exception of dopamine transporter single photon-emission computed tomography imaging in DLB, imaging has not yet been incorporated into the diagnostic criteria for the various dementia syndromes, but that will soon change. The recently formulated research criteria for early AD recently formulated by Dubois et al explicitly mention magnetic resonance imaging and positron emission tomography for AD, and are an example of a new diagnostic process developing. In this review, the various imaging techniques will be highlighted, with an emphasis on their ability to diagnose Alzheimer's disease and separate it from other entities. |
| publisher |
Les Laboratoires Servier |
| publishDate |
2009 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181915/ |
| _version_ |
1611478008207507456 |